Oppenheimer Downgrades Questcor Pharmaceuticals (QCOR) to Perform after Probe
Tweet
Share
E-mailGet Alerts QCOR Hot Sheet
Price: $93.60 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 14
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 14
Join SI Premium – FREE
Oppenheimer downgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Outperform to Perform following the U.S. probe into marketing practices.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals closed at $30.13 yesterday.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals closed at $30.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades Sirius XM Radio (SIRI) to Neutral, 'risk-reward is balanced at prevailing levels'
- Stifel Canada Downgrades Petrus Resources Ltd (PRQ:CN) (PTRUF) to Hold
- Morgan Stanley Downgrades Innolux Corp. (3481:TT) to Equalweight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
